Elliott Crouser, MD

Physician, Professor

Critical Care Medicine, Pulmonary Disease

Make an appointment

614-293-4925
Accepting new patients

Conditions and expertise

  • Pulmonary Sarcoidosis
  • Pulmonary Medicine
  • Intensive Care Units
  • Intensive Care
  • Sleep Disorders
  • Interstitial Lung Diseases

View all conditions

Locations

  • Lung Care

View location details

Academics and research

Department: Internal Medicine

View my research

About

Gender
Male

Biography

I am a board-certified pulmonary and critical care physician at The Ohio State University Wexner Medical Center. I specialize in sarcoidosis, interstitial lung disease, and intensive care medicine, providing expert care for patients with complex respiratory conditions.

My patients can rely on me for high-quality, compassionate care and honest communication. I collaborate with a multidisciplinary team to ensure each patient receives personalized treatment that supports both immediate recovery and long-term lung health.

Highlights

  • Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2016, 2017
  • Best Doctor in America 2017

Conditions and expertise

  • Intensive Care
  • Intensive Care Units
  • Interstitial Lung Diseases
  • Pulmonary Medicine
  • Pulmonary Sarcoidosis
  • Sleep Disorders

Locations

Lung Care

in Martha Morehouse Outpatient Care
2050 Kenny Road
Suite 2200
Columbus, OH 43221
614-293-4925

Please note: Not all physicians schedule patients at each listed location.

Credentials

Education

Fellowship - Pulmonary Disease
Ohio State University Wexner Medical Center, Columbus, OH, United States
7/1/1992 - 6/1/1996
Residency - Internal Medicine
Ohio State University Wexner Medical Center, Columbus, OH, United States
7/1/1990 - 6/1/1992
Internship - Internal Medicine
Ohio State University Wexner Medical Center, Columbus, OH, United States
6/1/1989 - 6/1/1990
Doctor of Medicine (MD)
University of Toledo College of Medicine, Toledo, OH
8/1/1985 - 6/30/1989

Certifications

  • American Heart Association National Center
    8/30/2024
  • American Board of Internal Medicine/Critical Care Medicine
    11/9/1995
  • American Board of Internal Medicine/Pulmonary Disease
    11/10/1994

Academics and research

In addition to my clinical responsibilities, I serve as a professor of Internal Medicine at The Ohio State University College of Medicine, where I am dedicated to advancing research and education in pulmonary and critical care medicine.

Research interests

  • Critical Care
  • Sarcoidosis

Additional Research Interests

Critical Care Research themes:

  • Mitochondrial mechanisms of organ failure during sepsis
  • Biomarkers for the early detection of sepsis in the hospital setting; particularly the monocyte distribution width (MDW), FDA approved (2020) for the detection of sepsis in adults admitted to the Emergency Department

Sarcoidosis Research themes:

  • Genomic studies of granulomas to determine disease mechanisms and to identify novel therapeutic targets
  • Clinical practice guidelines for the diagnosis and management of sarcoidosis
  • We established the first tractable laboratory disease model

Current Research

  • We are establishing novel biomarkers for early sepsis detection based on machine learning and employing the electronic medical record in conjunction with the US Government and FDA
  • We are investigating novel therapies for COVID-induced acute lung injury
  • We are conducting translational research in the field of pulmonary sarcoidosis to elicit disease mechanisms, establish novel biomarkers and to investigate novel therapies.

Awards and Honors

  • AOA, 1989
  • Professor of Medicine with Tenure, 2016
  • Star Research Awards, Society of Critical Care Medicine: 2017, 2019
  • Chair, Scientific Advisory Board; Foundation for Sarcoidosis Research 2021
  • President, Americas Association of Sarcoidosis and Other Granulomatous Disorders (AASOG) 2018-2020
  • Chair, American Thoracic Society Official Clinical Practice Guidelines for Sarcoidosis: 2017-2020
  • Chair, Internal Medicine Section (>4000 members); Society of Critical Care Medicine: 2019-2021

Active Funding

NIH/NIAID/UO1; 2022-2026:
Supplemental Citacoline Administration for Reducton of Lung Injury Efficacy Trial (SCARLET).
Multi-PIs- Crouser, Davis

Health and Human Services/BARDA/Beckman Coulter; 2020-2025:
Sepsis Early Warning Algorithm.
PI-Crouser

(pending) NIH/NIAID/R21; 12/2022-11/2024:
Role of Renin-Angiotensin-Aldosterone System during sarcoidosis granuloma formation.
PI- Crouser (impact score 17; pay line 2022 = impact score 28)

(pending) NIH/NHLBI/RO1:
Molecular Characterization of Progressive Pulmonary Sarcoidosis.
Multi-PIs: Crouser, Maier, Bhargava (Percentile score 15; payline 2022 = 15%)

Industry Research Contracts using Dr. Crouser’s proprietary in vitro sarcoidosis model to identify novel therapeutic targets, biomarkers and related disease mechanisms:

  • aTyr Pharmaceutical
  • Xentria Pharmaceutical
  • Star-Therapeutics Pharmaceutical
  • 23 & ME
  • Palleon Pharmaceutical

Academic information

Department:
Internal Medicine
Division:
Pulmonary, Critical Care and Sleep

More about my research

Ratings and reviews

The overall patient satisfaction rating is an average of all patient responses to the six doctor communication related questions shown below from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page.

The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of Ohio State Wexner Medical Center.

55 Patient Satisfaction Reviews

4.9 out of 5 overall
  • Explains Things Carefully
    4.9 / 5
  • Listens Carefully
    4.9 / 5
  • Gives Understandable Instructions
    4.9 / 5
  • Knows My Medical History
    4.9 / 5
  • Shows Respect
    5.0 / 5
  • Time Spent Together
    4.9 / 5

Patient Comments

  • Reviewed on Dec 01, 2025

    Same, he was concerned and passionate about my illness. Explained very well about the questions we had.

  • Reviewed on Nov 29, 2025

    Dr Crouser is the best!!

  • Reviewed on Nov 15, 2025

    Dr. Crouser was patient and helped to explain my other other health concerns as it related to sarcoidosis.

  • Reviewed on Nov 08, 2025

    Dr. Crouser is a wonderful doctor. I feel well cared for, he has helped keep me in good health despite the issues I have, and always makes sure that any questions I have are answered.

  • Reviewed on Sep 16, 2025

    He is one of the greatest providers I've ever had. Very caring, helpful, respectful of my wants, needs and concerns. I look up to him in the highest regards.

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 11/3/2025 Dr. Crouser has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.

  • Foundation for Sarcoidosis Research
  • Icahn School of Medicine at Mount Sinai
  • Sarcomed
  • Xentria Pharmaceutical

Subscribe. Get just the right amount of health and wellness in your inbox.